<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Regulatory actions</title>
    <description></description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Regulatory actions for July 31, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 3D Systems, Aspen, Capricor, Caristo, Cytokinetics, Immunitybio, J&amp;J, Nipro, Pfizer, Kelun, Smith+Nephew, Stevanato, Teleflex, VB Spine.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 3D Systems, Aspen, Capricor, Caristo, Cytokinetics, Immunitybio, J&J, Nipro, Pfizer, Kelun, Smith+Nephew, Stevanato, Teleflex, VB Spine.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/733039</guid>
      <pubDate>Fri, 31 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/733039-regulatory-actions-for-july-31-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 30, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Allogene, Amgen, Eton, Hopstem, Incyte, Insilico, Neuropace, Ocugen, Perspective, Polypid, Sandoz, Viatris, Voxneuro.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Allogene, Amgen, Eton, Hopstem, Incyte, Insilico, Neuropace, Ocugen, Perspective, Polypid, Sandoz, Viatris, Voxneuro.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/733027</guid>
      <pubDate>Thu, 30 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/733027-regulatory-actions-for-july-30-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 29, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Elevation, Grace, Haya, Implicity, Saol, Sunshine, Wandercraft.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Elevation, Grace, Haya, Implicity, Saol, Sunshine, Wandercraft.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732950</guid>
      <pubDate>Wed, 29 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732950-regulatory-actions-for-july-29-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 28, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Freenome, Masimo, Otsuka, Outlook, Surgentec.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Freenome, Masimo, Otsuka, Outlook, Surgentec.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732938</guid>
      <pubDate>Tue, 28 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732938-regulatory-actions-for-july-28-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 28, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Abelzeta, Astrazeneca, Daiichi Sankyo, Haisco, JCR, Junshi, Kyowa Kirin, Nuvectis, Seegene.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Abelzeta, Astrazeneca, Daiichi Sankyo, Haisco, JCR, Junshi, Kyowa Kirin, Nuvectis, Seegene.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732850</guid>
      <pubDate>Tue, 28 Jul 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732850-regulatory-actions-for-july-28-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 27, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma, Astrazeneca, Daiichi, Gilead, Mannkind, Menarini, Minoryx, Neuraxpharm, Newamsterdam, Roche, Zevra.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma, Astrazeneca, Daiichi, Gilead, Mannkind, Menarini, Minoryx, Neuraxpharm, Newamsterdam, Roche, Zevra.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732925</guid>
      <pubDate>Mon, 27 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732925-regulatory-actions-for-july-27-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 24, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Astrazeneca, Atsena, GSK, H. Lundbeck, Haisco, Ibex, Inhibikase, Momentis, Nuvectis, Pfizer, Revolution, Sentante, Traferox.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Astrazeneca, Atsena, GSK, H. Lundbeck, Haisco, Ibex, Inhibikase, Momentis, Nuvectis, Pfizer, Revolution, Sentante, Traferox.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732873</guid>
      <pubDate>Fri, 24 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732873-regulatory-actions-for-july-24-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 23, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Affinia, Bridgebio, JCR, Johnson &amp; Johnson, Junshi, Monopar, Orasure, Rapid.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Affinia, Bridgebio, JCR, Johnson & Johnson, Junshi, Monopar, Orasure, Rapid.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732861</guid>
      <pubDate>Thu, 23 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732861-regulatory-actions-for-july-23-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 22, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abelzeta, Intelligent, Kyowa, Mastel, Omeicos, Royal Philips, Seegene.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abelzeta, Intelligent, Kyowa, Mastel, Omeicos, Royal Philips, Seegene.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732771</guid>
      <pubDate>Wed, 22 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732771-regulatory-actions-for-july-22-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 21, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Almirall, Dyne, GSK, Oncolytics Biotech.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Almirall, Dyne, GSK, Oncolytics Biotech.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732759</guid>
      <pubDate>Tue, 21 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732759-regulatory-actions-for-july-21-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 21, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Aspen Pharmacare, Bioarctic, Clinuvel, Eisai, Orasis, Shionogi, Sichuan Biokin, Systimmune.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Aspen Pharmacare, Bioarctic, Clinuvel, Eisai, Orasis, Shionogi, Sichuan Biokin, Systimmune.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732777</guid>
      <pubDate>Tue, 21 Jul 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732777-regulatory-actions-for-july-21-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 20, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Allergan Aesthetics, Amneal, Boehringer, Camurus, Novartis, Sichuan, Systimmune, Vanda.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Allergan Aesthetics, Amneal, Boehringer, Camurus, Novartis, Sichuan, Systimmune, Vanda.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732746</guid>
      <pubDate>Mon, 20 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732746-regulatory-actions-for-july-20-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 17, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 4Teen4, Electrowire, Honeynaps, Merck, Novo Nordisk, Shionogi, Spinafx.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: 4Teen4, Electrowire, Honeynaps, Merck, Novo Nordisk, Shionogi, Spinafx.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732732</guid>
      <pubDate>Fri, 17 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732732-regulatory-actions-for-july-17-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 16, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aspen, Axsome, Celcuity, Meridian, Orasis, Roche.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aspen, Axsome, Celcuity, Meridian, Orasis, Roche.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732700</guid>
      <pubDate>Thu, 16 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732700-regulatory-actions-for-july-16-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 15, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Apnimed, Autonomous Healthcare, Bioarctic, Biogen, Dexcom, Eisai, Hologic, Merck, Personalis, Sotio.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Apnimed, Autonomous Healthcare, Bioarctic, Biogen, Dexcom, Eisai, Hologic, Merck, Personalis, Sotio.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732618</guid>
      <pubDate>Wed, 15 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732618-regulatory-actions-for-july-15-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 14, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Bavarian Nordic Biomarin, BMS, Claria, Clinuvel, Elevar, Enlivex, Eurofarma, Histosonics, Merck, Niagen, Oncolytics, Sydnexis, Tenpoint, Tolerogenixx, Universal, Zeta.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Bavarian Nordic Biomarin, BMS, Claria, Clinuvel, Elevar, Enlivex, Eurofarma, Histosonics, Merck, Niagen, Oncolytics, Sydnexis, Tenpoint, Tolerogenixx, Universal, Zeta.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732606</guid>
      <pubDate>Tue, 14 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732606-regulatory-actions-for-july-14-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 14, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Forus, Leads Biolabs, Pharmaessentia, SL Science.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Forus, Leads Biolabs, Pharmaessentia, SL Science.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732663</guid>
      <pubDate>Tue, 14 Jul 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732663-regulatory-actions-for-july-14-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 13, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Absentia Labs, Leads Biolabs, Sanofi, SL Science, Swedish Orphan.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Absentia Labs, Leads Biolabs, Sanofi, SL Science, Swedish Orphan.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732594</guid>
      <pubDate>Mon, 13 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732594-regulatory-actions-for-july-13-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 10, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord, Arialys, Ihealth, Intas, Natera, Octapharma, Roche.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Accord, Arialys, Ihealth, Intas, Natera, Octapharma, Roche.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732541</guid>
      <pubDate>Fri, 10 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732541-regulatory-actions-for-july-10-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 9, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Grünenthal, Immunome, J&amp;J, Merck, OS, Vanda, Vera.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Grünenthal, Immunome, J&J, Merck, OS, Vanda, Vera.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732527</guid>
      <pubDate>Thu, 09 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732527-regulatory-actions-for-july-9-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 8, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Beckman, Emmecell, Genmab, Movmedix, Organogenesis, Revolution, Saol.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agios, Beckman, Emmecell, Genmab, Movmedix, Organogenesis, Revolution, Saol.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732443</guid>
      <pubDate>Wed, 08 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732443-regulatory-actions-for-july-8-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 7, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Ascelia, Forus, Invivyd, Median, Pharmaessentia, Pharvaris, Visby.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Ascelia, Forus, Invivyd, Median, Pharmaessentia, Pharvaris, Visby.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732429</guid>
      <pubDate>Tue, 07 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732429-regulatory-actions-for-july-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 7, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Cansino, Daiichi Sankyo, Eisai, Hengrui, Hutchmed, Kowa, Novaliq, Nuvation.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Cansino, Daiichi Sankyo, Eisai, Hengrui, Hutchmed, Kowa, Novaliq, Nuvation.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732449</guid>
      <pubDate>Tue, 07 Jul 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732449-regulatory-actions-for-july-7-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 6, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Hutchmed, Novartis, Polaritybio, Tenon, Vertex.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Hutchmed, Novartis, Polaritybio, Tenon, Vertex.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732301</guid>
      <pubDate>Mon, 06 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732301-regulatory-actions-for-july-6-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 2, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Galderma, Intent, Kowa, Nicox, Orca, Penumbra, Scibase, Serenity, Siemens, Skylinedx.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Galderma, Intent, Kowa, Nicox, Orca, Penumbra, Scibase, Serenity, Siemens, Skylinedx.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732283</guid>
      <pubDate>Thu, 02 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732283-regulatory-actions-for-july-2-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 1, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Aurenar, Biomerieux, Cogent, Envoy, Hengrui, Monopar, Novaliq, Novocure, Praxis, Roche, Saluda, Sarepta, Starmed, Unicycive.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Aurenar, Biomerieux, Cogent, Envoy, Hengrui, Monopar, Novaliq, Novocure, Praxis, Roche, Saluda, Sarepta, Starmed, Unicycive.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732267</guid>
      <pubDate>Wed, 01 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732267-regulatory-actions-for-july-1-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 30, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Bavarian, Biodexa, Cansino, Capricor, Daiichi, Eisai, Lantheus, Larimar, Nuvation, Satellos, Senzime, SOBI, United, Viridian, Zambon.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Bavarian, Biodexa, Cansino, Capricor, Daiichi, Eisai, Lantheus, Larimar, Nuvation, Satellos, Senzime, SOBI, United, Viridian, Zambon.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732253</guid>
      <pubDate>Tue, 30 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732253-regulatory-actions-for-june-30-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 30, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Biokin, Carsgen, China Medical System, Daiichi Sankyo, Everest Medicines, Incyte Biosciences Japan, Merz, Natera, Novo Nordisk, Reprocell, Sanofi, Sumitomo, Systimmune, Teijin, Valgen Medtech.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Biokin, Carsgen, China Medical System, Daiichi Sankyo, Everest Medicines, Incyte Biosciences Japan, Merz, Natera, Novo Nordisk, Reprocell, Sanofi, Sumitomo, Systimmune, Teijin, Valgen Medtech.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732307</guid>
      <pubDate>Tue, 30 Jun 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732307-regulatory-actions-for-june-30-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 29, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Amgen, Arbor, Astrazeneca, Daiichi, Eli Lilly, Everest, Incyte, Johnson, Maat, Omeros, Pharmaessentia, Replimune, Xspray.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Amgen, Arbor, Astrazeneca, Daiichi, Eli Lilly, Everest, Incyte, Johnson, Maat, Omeros, Pharmaessentia, Replimune, Xspray.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732239</guid>
      <pubDate>Mon, 29 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732239-regulatory-actions-for-june-29-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 26, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aidoc, Celecor, Cercare, Deephealth, Gilead, Ionis, Merck, Pfizer, Radnet, Reprocell, Spectral, Sunshine.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aidoc, Celecor, Cercare, Deephealth, Gilead, Ionis, Merck, Pfizer, Radnet, Reprocell, Spectral, Sunshine.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732182</guid>
      <pubDate>Fri, 26 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732182-regulatory-actions-for-june-26-2026</link>
    </item>
  </channel>
</rss>
